Michael Tomsicek - ABIOMED CFO, Vice President Treasurer
President
Mr. Michael J. Tomsicek is the Chief Financial Officer, Vice President and Treasurer of Abiomed, Inc. From March 2013 until January 2015, Mr. Tomsicek served as Senior Vice President and Chief Financial Officer of Cubist Pharmaceuticals, Inc. . From July 2012 until March 2013, Mr. Tomsicek served as Senior Vice President and Deputy Financial Officer at Cubist and from August 2010 to July 2012, he was VicePresident of Corporationrationrate Finance and Treasurer at Cubist. Before joining Cubist, Mr. Tomsicek served for eight years holding roles with increasing influence within GEs Healthcare unit. His service at GE culminated in his roles first as Chief Financial Officer of the Diagnostic Ultrasound business and finally as Chief Financial Officer of the Global Ultrasound product group. Prior to that, Mr. Tomsicek was Manufacturing Finance Manager for the GE Healthcare Monitoring Systems business and was selected to and completed the GE Experienced Financial Leadership Program since 2015.
| Age | 50 |
| Tenure | 9 years |
| Professional Marks | MBA |
| Phone | 978 777-8411 |
| Web | www.abiomed.com |
ABIOMED Management Efficiency
The company has return on total asset (ROA) of 0.0955 % which means that it generated a profit of $0.0955 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1824 %, meaning that it created $0.1824 on every $100 dollars invested by stockholders. ABIOMED's management efficiency ratios could be used to measure how well ABIOMED manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 10 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. ABIOMED has a current ratio of 7.38, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist ABIOMED until it has trouble settling it off, either with new capital or with free cash flow. So, ABIOMED's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like ABIOMED sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for ABIOMED to invest in growth at high rates of return. When we think about ABIOMED's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Joseph Vortherms | CenterPoint Energy | 58 | |
| W Ash | Antero Midstream Partners | 41 | |
| Xia Liu | CenterPoint Energy | 49 | |
| David Piacquad | Amgen Inc | 61 | |
| Yuichi Tsujimoto | HUTCHMED DRC | 60 | |
| Kimberly Nooney | Black Hills | 52 | |
| Brian Iverson | Black Hills | 61 | |
| Lynne HarkelRumford | CenterPoint Energy | 67 | |
| Anita Romero | Southwest Gas Holdings | 55 | |
| Gregory Peterson | Southwest Gas Holdings | 62 | |
| Kevin Ellis | Antero Midstream Partners | N/A | |
| Sean Harper | Amgen Inc | 54 | |
| Kenneth Mercado | CenterPoint Energy | 57 | |
| William Rogers | CenterPoint Energy | 57 | |
| Murdo Gordon | Amgen Inc | 57 | |
| David Reese | Amgen Inc | 55 | |
| Esteban Santos | Amgen Inc | 56 | |
| Erik Keller | Black Hills | 60 | |
| Dana OBrien | CenterPoint Energy | 49 | |
| Justin Brown | Southwest Gas Holdings | 51 | |
| Kenneth Kenny | Southwest Gas Holdings | 61 | |
Management Performance
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0955 |
ABIOMED Leadership Team
Elected by the shareholders, the ABIOMED's board of directors comprises two types of representatives: ABIOMED inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ABIOMED. The board's role is to monitor ABIOMED's management team and ensure that shareholders' interests are well served. ABIOMED's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ABIOMED's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Minogue, Chairman, CEO and President Member of Special Stock Option Committee and Member of Executive Committee | ||
| Paul Thomas, Independent Director | ||
| Andrew Greenfield, Vice President - Healthcare Solutions | ||
| Jeannine Rivet, Director | ||
| Ingrid Ward, Director Relations | ||
| Todd Trapp, CFO, Vice President | ||
| Christopher Gorder, Director | ||
| David Weber, Scientific Advisor | ||
| Ian McLeod, Principal Financial Officer, Principal Accounting Officer, Vice President Controller | ||
| Martin Sutter, Independent Director | ||
| Michael Howley, VP and General Manager of Global Sales | ||
| Henri Termeer, Independent Director | ||
| Thorsten Siess, Ex Officer | ||
| William Bolt, Sr. VP of Global Product Operations | ||
| Ingrid Goldberg, Director - Investor Relations | ||
| Matthew Plano, Ex Integration | ||
| Dorothy Puhy, Lead Independent Director | ||
| Michael Tomsicek, CFO, Vice President Treasurer | ||
| Sarah Karr, Communications Mang | ||
| Marc Began, Gen VP | ||
| Eric Rose, Director | ||
| Gerald Austen, Independent Director |
ABIOMED Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ABIOMED a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0955 | |||
| Profit Margin | 0.25 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 16.32 B | |||
| Shares Outstanding | 45.09 M | |||
| Shares Owned By Insiders | 2.02 % | |||
| Shares Owned By Institutions | 97.00 % | |||
| Number Of Shares Shorted | 753.62 K | |||
| Price To Earning | 76.38 X |
Pair Trading with ABIOMED
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ABIOMED position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABIOMED will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to ABIOMED could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ABIOMED when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ABIOMED - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ABIOMED to buy it.
The correlation of ABIOMED is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ABIOMED moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ABIOMED moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ABIOMED can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in ABIOMED Stock
If you are still planning to invest in ABIOMED check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ABIOMED's history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |